Aclarion hits another key milestone by adding vitality - third major payer to cover nociscan in greater uk

Broomfield, co, aug. 13, 2024 (globe newswire) -- aclarion, inc., (“aclarion” or the “company”) (nasdaq: acon, aconw), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today their third payer coverage of nociscan by vitality in london, uk in conjunction with the london clinic, one of the uk's largest and most renowned independent hospitals. with the addition of coverage by vitality, payer coverage for nociscan is now available from three major private medical insurance groups in the uk, a global healthcare market with more than nine million residents.
ACON Ratings Summary
ACON Quant Ranking